In the News

1893 News Items found
Dr. Bob Li
The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.
pancreatic surgeon and K12 alum Vinod Balachandran
In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
MSK medical oncologist Smita Joshi, who specializes in esophageal cancer.
Q&A
There is very little evidence that drinking hot beverages increases esophageal cancer risk.
Man putting on sunscreen
First, the good news: There’s no evidence that tattoos cause skin cancer, says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFa...
Memorial Sloan Kettering Cancer Center physician-scientist Richard Wong
Pancreatic cancer cells spread with the help of tracks laid by nerve-supporting cells called Schwann cells.
bowl of edamame
Learn whether eating soy products causes cancer.
Medical oncologist Emily Feld
Q&A
In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
Hematologic oncologist Urvi Shah
Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
SKI molecular biologist John Maciejowski
A protein in the body that protects against viruses can also cause cancer-related mutations.
Jason Mascolo with his wife, Tricia, and daughter, Maeve
In the Clinic
Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.